UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multivariable sliding mode control for autonomous diving and steering of unmanned underwater vehicles

IEEE journal of oceanic engineering, 1993-07, Vol.18 (3), p.327-339

1993

Volltextzugriff (PDF)

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

Journal of clinical oncology, 1992-01, Vol.10 (1), p.52-60

1992

Volltextzugriff (PDF)

Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6747-6755

2005

Volltextzugriff (PDF)

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2653-2665

1996

Volltextzugriff (PDF)

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Journal of clinical oncology, 2005-12, Vol.23 (35), p.9008-9021

2005

Volltextzugriff (PDF)

On the release and half‐life of S100B protein in the peripheral blood of melanoma patients

International journal of cancer, 2001-11, Vol.94 (4), p.586-590

2001

Volltextzugriff (PDF)

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

Annals of surgery, 1996-12, Vol.224 (6), p.756-765

1996

Volltextzugriff (PDF)

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2579-2588

1997

Volltextzugriff (PDF)

Utilité du blian initial pour les mélanomes de stade I

Annales de dermatologie et de vénéréologie, 1995, Vol.122 (5), p.285-288

LIENARD, D

1995

Volltextzugriff (PDF)

Administration de haute dose de tumor necrosis factor-alpha (TNFα) en isolation perfusion des membres

Pathologie et biologie, 1994, Vol.42 (10), p.1073-1074

1994

Volltextzugriff (PDF)

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study

Melanoma research, 1999-10, Vol.9 (5), p.491-502

1999

Volltextzugriff (PDF)

P034. Single-institution experience in an extended access program with the CTLA-4 blocking monoclonal antibody ipilimumab in pretreated melanoma patients

Melanoma research, 2011-06, Vol.21, p.e35-e36

2011

Volltextzugriff (PDF)

Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant

Journal of immunotherapy, 2009-10, Vol.32 (8), p.875-883

2009

Volltextzugriff (PDF)

Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma

Journal of immunotherapy, 2007-02, Vol.30 (2), p.240-250

2007

Volltextzugriff (PDF)

Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany

Melanoma research, 1994-04, Vol.4 (2), p.79-85

1994

Volltextzugriff (PDF)

FC18 Clinical outcome following therapeutic vaccination with autologous mRNA electroporated dendritic cell vaccines in patients with advanced melanoma

Melanoma research, 2010-06, Vol.20, p.e37

2010

Volltextzugriff (PDF)

Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study

Melanoma research, 1994-03, Vol.4 Suppl 1, p.21

1994

Volltextzugriff (PDF)

Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods

Melanoma research, 2003-10, Vol.13 (5), p.511-520

2003

Volltextzugriff (PDF)

264 Strong Melan-A/MART-1 specific CD8+ T cell responses to peptide vaccination in young melanoma patients

European journal of cancer supplements, 2004-09, Vol.2 (8), p.81-81

2004

Volltextzugriff (PDF)

25 Update of EORTC melanoma trials. Final results of the EORTC melanoma group trials: EORTC 18951 in stage IV and EORTC 18952 in stage IIB–III

Melanoma research, 2004-08, Vol.14 (4), p.A11-A12

2004

Volltextzugriff (PDF)

Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: a descriptive study in Belgium

Melanoma research, 1991-04, Vol.1 (1), p.69

1991

Volltextzugriff (PDF)

The EORTC Melanoma Group: a comprehensive melanoma research programme by clinicians and scientists

European journal of cancer supplements, 2002, Vol.38 (4), p.S114-S119

2002

Volltextzugriff (PDF)

Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system

Melanoma research, 1997-08, Vol.7 Suppl 2, p.S43

1997

Volltextzugriff (PDF)

1067 Analysis of the EORTC Melanoma Group 18952 randomized trial on 2 intermediate dose schedules of IFN-alpha2b compared with observation in 1388 patients with high risk melanoma stages IIB-III

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S319-S319

2003

Volltextzugriff (PDF)

Disseminated melanoma, preclinical therapeutic studies, clinical trials, and patient treatment

Current opinion in oncology, 1993-03, Vol.5 (2), p.390-396

1993

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multivariable sliding mode control for autonomous diving and steering of unmanned underwater vehicles

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

On the release and half‐life of S100B protein in the peripheral blood of melanoma patients

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

Utilité du blian initial pour les mélanomes de stade I

Administration de haute dose de tumor necrosis factor-alpha (TNFα) en isolation perfusion des membres

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study

P034. Single-institution experience in an extended access program with the CTLA-4 blocking monoclonal antibody ipilimumab in pretreated melanoma patients

Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant

Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma

Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany

FC18 Clinical outcome following therapeutic vaccination with autologous mRNA electroporated dendritic cell vaccines in patients with advanced melanoma

Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study

Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods

264 Strong Melan-A/MART-1 specific CD8+ T cell responses to peptide vaccination in young melanoma patients

25 Update of EORTC melanoma trials. Final results of the EORTC melanoma group trials: EORTC 18951 in stage IV and EORTC 18952 in stage IIB–III

Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: a descriptive study in Belgium

The EORTC Melanoma Group: a comprehensive melanoma research programme by clinicians and scientists

Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system

1067 Analysis of the EORTC Melanoma Group 18952 randomized trial on 2 intermediate dose schedules of IFN-alpha2b compared with observation in 1388 patients with high risk melanoma stages IIB-III

Disseminated melanoma, preclinical therapeutic studies, clinical trials, and patient treatment

Aktive Filter

Suchergebnisse filtern